NINDS Neuroscience Funding Announcements

Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

Parkinson Disease Neuroprotection Clinical Trial: Coordinating and Statistical Centers
Release Date: February 27, 2001
Announcement Number: RFA-NS-01-012
Application Receipt Date:
May 15, 2001
Letter of Intent Date: March 30, 2001

Funding Contact: Scott Janis, Ph.D.
Program Area: Clinical Trials

Brief Description:
The Neurodegeneration and Clinical Trial Groups of the National Institute of Neurological Disorders and Stroke (NINDS) request applications for centers to collaborate in the performance of a large, double-blind randomized trial of two or more potential neuroprotective agents in patients early in the course of Parkinson’s disease. Two types of applications are requested: for (1) a Coordinating Center, and (2) a Statistical Center.

Choose an option to view additional funding announcements